This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

275 result(s)

Ellipta inhaler products | GSKpro

27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.

GSKpro for UK healthcare professionals

A portal for UK healthcare professionals containing GSK product information, patient resources, exclusive webinars and more

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

GSK support for healthcare professionals in response to COVID-19

Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.

Head-to-head data | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) head-to-head data to support UK healthcare professionals

Guidelines | Anoro▼ Ellipta (umeclidinium / vilanterol)

COPD guidelines information relevant to Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) information to support UK healthcare professionals

vs. LAMA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA head-to-head data to support UK healthcare professionals

vs. LAMA/LABA | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) vs. LAMA/LABA head-to-head data to support UK healthcare professionals

Anoro Patient | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) patient profile information intended to support UK healthcare professionals

Molecules | Anoro▼ Ellipta (umeclidinium / vilanterol)

Information about the molecules in Anoro▼ Ellipta (umeclidinium / vilanterol) to support UK healthcare professionals

Webinars & events | GSKpro

A collection of promotional events and webinars featuring experts for UK healthcare professionals

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

Efficacy

Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.

BLENREP▼

belantamab mafodotin<br> Oncology

Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Patient Profiles | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Report a possible side effect | GSKpro

Information for UK healthcare professionals on how to report an adverse event related to a GSK product

Contact | GSKpro UK

GSK UK contact page for healthcare professionals.

Dosing & Device | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) dosing & device information to support UK healthcare professionals

Safety | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Cost | Anoro▼ Ellipta (umeclidinium / vilanterol)

Anoro▼ Ellipta (umeclidinium / vilanterol) safety information to support UK healthcare professionals

Coming soon | GSKpro

This page is under construction. If you require assistance, please connect with our Customer Support team via live chat or request to be contacted by a suitable GSK contact.

Request a contact

Contact us form for UK healthcare professionals to contact GSK

Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

PHN-Efficacy | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

FAQ | Supply | GSKpro

Frequently asked questions around the supply and availability of GSK medicines and vaccines.

Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Scientific Rationale | SHINGRIX▼ (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Respiratory

Overview of COPD and severe asthma.

ZEJULA▼

niraparib<br>Oncology

Experts’ perspectives | Anoro▼ Ellipta (umeclidinium / vilanterol)

Experts' perspectives and patient case study videos relevant to the LAMA/LABA class to support UK healthcare professionals

Guidelines |Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)| GSKPro

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

DECTOVA▼

zanamivir IV</br> Influenza

XEVUDY ▼ (sotrovimab)

XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Great Britain, including summary of product characteristics and patient information leaflet.

XEVUDY ▼ (sotrovimab)

XEVUDY▼ (sotrovimab) label information for patients and healthcare professionals in Northern Ireland, including summary of product characteristics and patient information leaflet.

Optimising the Paediatric Severe Asthma Journey Webinar Recording

Optimising the Paediatric Severe Asthma Journey Webinar Recording

Cost | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) price information to support UK Healthcare Professionals

Identifying Patients | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals

Lung Function | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

HRQoL | Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK healthcare professionals

Therapy areas | GSKpro UK

Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.

Therapy areas | GSKpro UK

Learn about GSK’s product portfolio in respiratory, vaccines, oncology and more. This page is for UK healthcare professionals only.

Molecules | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals

BLENREP▼ (belantamab mafodotin)

BLENREP▼ (belantamab mafodotin) product information for healthcare professionals detailing the efficacy, safety and dosing data

Nucala (mepolizumab)

See the safety profile and efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.

Efficacy | Nucala (mepolizumab)

See the efficacy data for Nucala (mepolizumab) to support UK Healthcare Professionals.

Resources | Nucala (mepolizumab)

For UK Healthcare Professionals - view resources to support you and your patients using Nucala (mepolizumab).

Nucala (mepolizumab)

Nucala (mepolizumab) information to support UK healthcare professionals.

Dosing & Administration | Nucala (mepolizumab)

Read more about the dosing and administration of Nucala (mepolizumab) to support UK Healthcare Professionals.

Expert Perspectives | Nucala (mepolizumab)

For UK Healthcare Professionals - see what the experts have to say about Nucala (mepolizumab).

Safety Information | Nucala (mepolizumab)

See the safety profile of Nucala (mepolizumab) to support UK Healthcare Professionals.

Exacerbations| Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals

Video Testimonials: I've Seen Meningitis

Video testimonials from healthcare professionals about the impact of meningitis

XEVUDY ▼ (for GB HCPs)

sotrovimab <br>COVID-19 therapeutics

JEMPERLI ▼

dostarlimab<br>Oncology

Products | GSKpro

GSK product information for UK healthcare professionals

Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for UK healthcare professionals

Real world evidence | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for UK healthcare professionals

Invasive Meningococcal Disease I Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for UK healthcare professionals

Safety | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for UK healthcare professionals

Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Dose & Device| Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) dosing and device information to support UK Healthcare Professionals

Sustainability | GSKpro

Information for UK healthcare professionals on GSK’s carbon neutral inhaler and strategy.

Vaccines

GSK UK information about our vaccines and disease awareness campaigns

Real world evidence

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) data from real world evidence studies to support UK Healthcare Professionals

Oncology | GSKpro

Oncology at GSK covers a range of therapy areas including ovarian cancer and multiple myeloma. Explore the Oncology GSK resources available to support your appropriate cancer patients.

Safety in PRIMA | ZEJULA ▼ (niraparib)

The safety profile and adverse events of ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Resources | ZEJULA ▼ (niraparib)

Resources for UK healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only.

Efficacy in the PRIMA trial | ZEJULA ▼ (niraparib)

The efficacy data for ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Mechanism of action | ZEJULA ▼ (niraparib)

Overview of the mechanism of action for ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Dosing in PRIMA | ZEJULA ▼ (niraparib)

Recommended dosing for ZEJULA ▼ (niraparib) and dosing in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

HCP resources | ZEJULA ▼ (niraparib)

Expert lead video content, congress highlights and downloadable resources for healthcare professionals | This website contains promotional information about ZEJULA ▼ (niraparib) and is for UK healthcare professionals only

Patient support for healthcare professionals | ZEJULA ▼ (niraparib)

Resources for healthcare professionals to support patients who have been prescribed ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Patient support & Resources | Seretide (salmeterol/fluticasone propionate)

Seretide (salmeterol/fluticasone propionate) patient support and resources for UK healthcare professionals

Home | Seretide (Salmeterol/fluticasone propionate)

Seretide (Salmeterol/fluticasone propionate) information to support UK health professionals.

ZEJULA ▼ (niraparib)

Overview of ZEJULA ▼ (niraparib) | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Efficacy & safety data | Seretide (salmeterol/fluticasone propionate)

Seretide (salmeterol/fluticasone propionate) efficacy & safety data for UK healthcare professionals

Discontinued products | GSK Pro

Discontinued products

Dosing and administration | Bexsero Meningococcal Group B Vaccine (rDNA, component, adsorbed)

Bexsero prescribing information for UK healthcare professionals

Seretide (salmeterol/fluticasone propionate) vs. other ICS/LABAs

Information about the comparison between Seretide (salmeterol/fluticasone propionate) and other ICS/LABAs for UK healthcare professionals

Safety Information | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals

Home | Trelegy▼Ellipta (fluticasone furoate/umeclidinium/vilanterol)

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) information to support UK Healthcare Professionals

Quality of life in PRIMA | ZEJULA ▼ (niraparib)

Quality of life data about ZEJULA ▼ (niraparib) in the PRIMA clinical trial | This website contains promotional information about ZEJULA and is for UK healthcare professionals only

Medicines management and optimisation

For UK healthcare professionals Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

Resources | GSKpro

Support your patients and practice with these healthcare resources, ranging from training devices to patient support information.

Identifying Patients | Nucala (mepolizumab)

Identify which patients are suitable for treatment with Nucala (mepolizumab) to support UK Healthcare Professionals.

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more